TMCnet News
Global Gout Epidemiology and Patient Flow Analysis - 2017 - Research and MarketsResearch and Markets has announced the addition of the "Global Gout Epidemiology and Patient Flow Analysis - 2017" report to their offering. The results of the Gout patients study are announced in this new report Global Gout Epidemiology and Patient Flow Analysis - 2017'. The report provides insights into Gout epidemiology, Gout diagnosed patients, and Gout treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Gout derived from epidemiological analysis, percentage of patients diagnosed with Gout, and percentage of patients treated with a therapy. The study helps executives estimate Gout market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evauate market opportunities, effectively identify target patient population, and align marketing decisions. The report provides estimates and forecasts of Gout prevalence, Gout diagnosis rate, and Gout treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources. Key Features of the Report:
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/wxbpjs/global_gout View source version on businesswire.com: http://www.businesswire.com/news/home/20170116005697/en/ |
